Trials / Unknown
UnknownNCT04182386
Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Several aspects on the use of portal vein embolization (PVE) are poorly studied and todays recommendations are based on low-grade evidence. In this Scandinavian multicenter cohort study we will study some of the controversial aspects on the use of PVE to try to provide clearer answers on its optimal use. Six tertiary university hospital hepatobiliary units in Sweden, Norway and Denmark participate and contribute with all PVE procedures performed at their units during the study period. We will then study several aspects PVE technique in relation to induced hypertrophy and surgical outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Portal vein embolization | Selective preoperative portal vein embolization |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2021-12-31
- Completion
- 2022-12-31
- First posted
- 2019-12-02
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04182386. Inclusion in this directory is not an endorsement.